$CBDY
Target Group Inc. Stock $cbdy

$cbdy Overview Financials Valuation SEC Filings Company Website

2023 Q1 Form 10-K Financial Statement

#000141057823000283 Filed on March 17, 2023

Income Statement

Concept	2023 Q1	2022 Q4	2022
Revenue	$0.00	$0.00	$0.00
YoY Change
Cost Of Revenue			$0.00
YoY Change
Gross Profit			$0.00
YoY Change
Gross Profit Margin
Selling, General & Admin	$136.3K	$340.3K	$1.263M
YoY Change	-55.07%	204.07%	21.59%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$212.7K	$211.9K	$885.2K
YoY Change	-6.56%	-11.86%	-8.88%
% of Gross Profit
Operating Expenses	$340.7K	$326.3K	$1.240M
YoY Change	-2.15%	56.82%	-8.16%
Operating Profit			-$1.240M
YoY Change			-8.16%
Interest Expense	$353.6K	-$245.1K	$1.122M
YoY Change	22.49%	-283.88%	13.79%
% of Operating Profit
Other Income/Expense, Net	-$405.0K	$64.34K	-$3.281M
YoY Change	91.48%	344.34%	-302.18%
Pretax Income	-$745.7K	-$3.922M	-$4.520M
YoY Change	33.23%	6367.38%	-1756.42%
Income Tax	$0.00	$0.00	$0.00
% Of Pretax Income
Net Earnings	-$745.7K	-$3.922M	-$4.520M
YoY Change	33.23%	6367.38%	-1756.42%
Net Earnings / Revenue
Basic Earnings Per Share	$0.00		-$0.01
Diluted Earnings Per Share	$0.00	-$0.01	-$0.01
COMMON SHARES
Basic Shares Outstanding	617.0M	617.0M	617.0M
Diluted Shares Outstanding	617.0M		617.0M

Balance Sheet

Concept	2023 Q1	2022 Q4	2022
SHORT-TERM ASSETS
Cash & Short-Term Investments	$49.34K	$223.8K	$223.8K
YoY Change	-74.66%	97.95%	97.95%
Cash & Equivalents	$57.83K	$232.3K
Short-Term Investments
Other Short-Term Assets	$685.2K	$680.4K	$680.4K
YoY Change	93.48%	97.5%	97.5%
Inventory	$0.00	$0.00	$0.00
Prepaid Expenses	$41.75K	$41.71K
Receivables	$2.068K	$2.068K	$2.070K
Other Receivables	$18.78K	$3.690K	$3.690K
Total Short-Term Assets	$755.4K	$910.0K	$910.0K
YoY Change	15.52%	55.76%	55.76%
LONG-TERM ASSETS
Property, Plant & Equipment	$5.346M	$5.554M	$5.617M
YoY Change	-20.34%	-18.82%	-18.91%
Goodwill	$263.3K	$263.1K
YoY Change	-92.95%	-92.85%
Intangibles
YoY Change
Long-Term Investments	$1.270M	$775.6K	$775.6K
YoY Change	-39.04%	-58.53%	-58.53%
Other Assets
YoY Change
Total Long-Term Assets	$6.938M	$6.656M	$6.656M
YoY Change	-44.99%	-46.66%	-46.66%
TOTAL ASSETS
Total Short-Term Assets	$755.4K	$910.0K	$910.0K
Total Long-Term Assets	$6.938M	$6.656M	$6.656M
Total Assets	$7.694M	$7.566M	$7.566M
YoY Change	-42.01%	-42.08%	-42.08%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$7.582M	$5.120M	$5.120M
YoY Change	320.48%	326.57%	326.57%
Accrued Expenses	$112.9K	$1.792M	$1.792M
YoY Change	-95.13%	-11.6%	-11.6%
Deferred Revenue
YoY Change
Short-Term Debt	$990.00	$990.00	$990.00
YoY Change	0.0%	0.0%	0.0%
Long-Term Debt Due	$1.632M	$1.737M	$4.469M
YoY Change	41.35%	188.7%
Total Short-Term Liabilities	$7.708M	$6.927M	$6.927M
YoY Change	50.11%	71.33%	71.33%
LONG-TERM LIABILITIES
Long-Term Debt	$6.069M	$5.958M	$5.878M
YoY Change	-17.18%	-23.22%	-38.91%
Other Long-Term Liabilities	$1.292M	$1.320M	$1.320M
YoY Change	-15.13%	-14.84%	-14.84%
Total Long-Term Liabilities	$7.293M	$7.198M	$7.198M
YoY Change	-32.68%	-35.57%	-35.57%
TOTAL LIABILITIES
Total Short-Term Liabilities	$7.708M	$6.927M	$6.927M
Total Long-Term Liabilities	$7.293M	$7.198M	$7.198M
Total Liabilities	$15.00M	$14.13M	$14.13M
YoY Change	-6.06%	-7.16%	-7.16%
SHAREHOLDERS EQUITY
Retained Earnings	-$31.53M	-$30.78M
YoY Change	17.54%	17.21%
Common Stock	$61.70K	$61.70K
YoY Change	0.0%	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$7.307M	-$6.560M	-$6.560M
YoY Change
Total Liabilities & Shareholders Equity	$7.694M	$7.566M	$7.566M
YoY Change	-42.01%	-42.08%	-42.08%

Cashflow Statement

Concept	2023 Q1	2022 Q4	2022
OPERATING ACTIVITIES
Net Income	-$745.7K	-$3.922M	-$4.520M
YoY Change	33.23%	6367.38%	-1756.42%
Depreciation, Depletion And Amortization	$212.7K	$211.9K	$885.2K
YoY Change	-6.56%	-11.86%	-8.88%
Cash From Operating Activities	-$186.8K	$55.38K	-$1.015M
YoY Change	-226.15%	-90.89%	-1113.63%
INVESTING ACTIVITIES
Capital Expenditures	$0.00	-$10.00	$310.00
YoY Change	-100.0%
Acquisitions
YoY Change
Other Investing Activities	-$538.9K	-$225.1K	$1.015M
YoY Change	290.51%	-53.73%	-172.22%
Cash From Investing Activities	-$538.9K	-$225.1K	$1.015M
YoY Change	289.6%	-53.35%	-172.2%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	554.6K	193.1K	122.7K
YoY Change	703.93%	-565.14%	-90.2%
NET CHANGE
Cash From Operating Activities	-186.8K	55.38K	-1.015M
Cash From Investing Activities	-538.9K	-225.1K	1.015M
Cash From Financing Activities	554.6K	193.1K	122.7K
Net Change In Cash	-171.1K	23.39K	122.9K
YoY Change	-317.44%	-72.15%	-326.06%
FREE CASH FLOW
Cash From Operating Activities	-$186.8K	$55.38K	-$1.015M
Capital Expenditures	$0.00	-$10.00	$310.00
Free Cash Flow	-$186.8K	$55.39K	-$1.015M
YoY Change	-225.88%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2021	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-73163
CY2022	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	811464
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.0073
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.0001
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	617025999
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	595347680
CY2022	dei	Entity Central Index Key EntityCentralIndexKey	0001586554
CY2022	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2022	dei	Amendment Flag AmendmentFlag	false
CY2022	dei	Trading Symbol TradingSymbol	CBDY
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2022	dei	Document Type DocumentType	10-K
CY2022	dei	Document Annual Report DocumentAnnualReport	true
CY2022	dei	Document Period End Date DocumentPeriodEndDate	2022-12-31
CY2022	dei	Document Transition Report DocumentTransitionReport	false
CY2022	dei	Entity File Number EntityFileNumber	000-55066
CY2022	dei	Entity Registrant Name EntityRegistrantName	TARGET GROUP INC.
CY2022	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2022	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	46-3621499
CY2022	dei	Entity Address Address Line1 EntityAddressAddressLine1	20 Hempstead DriveHamilton
CY2022	dei	Entity Address City Or Town EntityAddressCityOrTown	Ontario
CY2022	dei	Entity Address Country EntityAddressCountry	CA
CY2022	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	L8W 2E7
CY2022	dei	City Area Code CityAreaCode	+1 905
CY2022	dei	Local Phone Number LocalPhoneNumber	541-3833
CY2022	dei	Security12g Title Security12gTitle	Common Stock, Par Value $0.0001
CY2022	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2022	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2022	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022	dei	Entity Small Business EntitySmallBusiness	true
CY2022	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2022	dei	Entity Shell Company EntityShellCompany	false
CY2022Q2	dei	Entity Public Float EntityPublicFloat	4627695
CY2023Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	617025999
CY2022	dei	Auditor Firm AuditorFirmId	5525
CY2022	dei	Auditor Location AuditorLocation	Spokane, Washington
CY2022Q4	us-gaap	Cash Cash	223843
CY2021Q4	us-gaap	Cash Cash	113079
CY2022Q4	us-gaap	Restricted Cash RestrictedCash	8490
CY2021Q4	us-gaap	Restricted Cash RestrictedCash	9072
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2068
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2068
CY2021Q4	us-gaap	Inventory Net InventoryNet	99000
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	41714
CY2021Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	44567
CY2021Q4	us-gaap	Value Added Tax Receivable Current ValueAddedTaxReceivableCurrent	21637
CY2022Q4	us-gaap	Due From Joint Ventures Current DueFromJointVenturesCurrent	630180
CY2021Q4	us-gaap	Due From Joint Ventures Current DueFromJointVenturesCurrent	290855
CY2022Q4	us-gaap	Other Receivables OtherReceivables	3692
CY2021Q4	us-gaap	Other Receivables OtherReceivables	3944
CY2022Q4	us-gaap	Assets Current AssetsCurrent	909987
CY2021Q4	us-gaap	Assets Current AssetsCurrent	584222
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5554225
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	6841770
CY2022Q4	us-gaap	Equity Method Investments EquityMethodInvestments	775577
CY2021Q4	us-gaap	Equity Method Investments EquityMethodInvestments	1870123
CY2022Q4	us-gaap	Goodwill Goodwill	263117
CY2021Q4	us-gaap	Goodwill Goodwill	3682236
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	62728
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	84618
CY2022Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	6655647
CY2021Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	12478747
CY2022Q4	us-gaap	Assets Assets	7565634
CY2021Q4	us-gaap	Assets Assets	13062969
CY2022Q4	us-gaap	Bank Overdrafts BankOverdrafts	506
CY2021Q4	us-gaap	Bank Overdrafts BankOverdrafts	506
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	2296935
CY2021Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	2885909
CY2021Q4	us-gaap	Settlement Liabilities Current SettlementLiabilitiesCurrent	10000
CY2022Q4	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	35254
CY2022Q4	us-gaap	Accounts Payable Related Parties Current AccountsPayableRelatedPartiesCurrent	4468535
CY2021Q4	us-gaap	Accounts Payable Related Parties Current AccountsPayableRelatedPartiesCurrent	1037104
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	110586
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	101356
CY2022Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	480
CY2021Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	480
CY2022Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	15125
CY2021	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	30769
CY2021Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	7902
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	6927421
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	4043257
CY2022Q4	us-gaap	Accounts Payable Related Parties Noncurrent AccountsPayableRelatedPartiesNoncurrent	5877930
CY2021Q4	us-gaap	Accounts Payable Related Parties Noncurrent AccountsPayableRelatedPartiesNoncurrent	9621696
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1319619
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1528033
CY2022Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	489
CY2021Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	22095
CY2022Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	7198038
CY2021Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	11171824
CY2022Q4	us-gaap	Liabilities Liabilities	14125459
CY2021Q4	us-gaap	Liabilities Liabilities	15215081
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue	100
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue	100
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	61703
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	61703
CY2022Q4	cbdy	Shares To Be Issued Total SharesToBeIssuedTotal	175182
CY2021Q4	cbdy	Shares To Be Issued Total SharesToBeIssuedTotal	174722
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	24985697
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	24985697
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-30783678
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-26263614
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-998829
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1110720
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-6559825
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-2152112
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	7565634
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	13062969
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	0
CY2022	us-gaap	Professional Fees ProfessionalFees	18926
CY2021	us-gaap	Professional Fees ProfessionalFees	21702
CY2022	us-gaap	Management Fee Expense ManagementFeeExpense	143677
CY2021	us-gaap	Management Fee Expense ManagementFeeExpense	149819
CY2021	cbdy	Salary And Wage Nonofficer SalaryAndWageNonofficer	9271
CY2022	us-gaap	Legal Fees LegalFees	243670
CY2021	us-gaap	Legal Fees LegalFees	232151
CY2022	us-gaap	Depreciation Depreciation	885229
CY2021	us-gaap	Depreciation Depreciation	971524
CY2022	cbdy	Operating Lease Income Expense OperatingLeaseIncomeExpense	74059
CY2021	cbdy	Operating Lease Income Expense OperatingLeaseIncomeExpense	-1761
CY2022	cbdy	General And Administrative Income Expense GeneralAndAdministrativeIncomeExpense	-22071
CY2021	cbdy	General And Administrative Income Expense GeneralAndAdministrativeIncomeExpense	17991
CY2022	us-gaap	Operating Expenses OperatingExpenses	1239514
CY2021	us-gaap	Operating Expenses OperatingExpenses	1349695
CY2022	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	14383
CY2021	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	2930894
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	26049
CY2022	us-gaap	Interest Expense InterestExpense	1121595
CY2021	us-gaap	Interest Expense InterestExpense	985634
CY2022	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	126314
CY2022	cbdy	Allowance Recovery For Sales Tax Recoverable AllowanceRecoveryForSalesTaxRecoverable	496
CY2021	cbdy	Allowance Recovery For Sales Tax Recoverable AllowanceRecoveryForSalesTaxRecoverable	19453
CY2022	cbdy	Impairment Of Inventory ImpairmentOfInventory	99000
CY2021	cbdy	Impairment Of Inventory ImpairmentOfInventory	0
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	3315749
CY2021	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0
CY2022	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	354736
CY2021	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-272995
CY2022	cbdy	Debt Issuance Costs DebtIssuanceCosts	51599
CY2021	cbdy	Debt Issuance Costs DebtIssuanceCosts	52797
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-3280550
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1622576
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-4520064
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	272881
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-4520064
CY2021	us-gaap	Net Income Loss NetIncomeLoss	272881
CY2022	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	111891
CY2021	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	64249
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-4408173
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	337130
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.0073
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.0001
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	617025999
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	595347680
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-2152112
CY2022	cbdy	Shares To Be Issued As Compensation To Intellectual Property Rights Value SharesToBeIssuedAsCompensationToIntellectualPropertyRightsValue	460
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-4520064
CY2022	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	111891
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-6559825
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	-3521219
CY2021	cbdy	Shares To Be Issued As Compensation To Intellectual Property Rights Value SharesToBeIssuedAsCompensationToIntellectualPropertyRightsValue	1294
CY2021	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	2648
CY2021	cbdy	Adjustments To Additional Paid In Capital Extinguishment Of Derivative Liability Upon Conversion Of Notes AdjustmentsToAdditionalPaidInCapitalExtinguishmentOfDerivativeLiabilityUponConversionOfNotes	228
CY2021	cbdy	Stock Held During Period Value New Issues StockHeldDuringPeriodValueNewIssues	1027807
CY2021	us-gaap	Net Income Loss NetIncomeLoss	272881
CY2021	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	64249
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-2152112
CY2022	us-gaap	Profit Loss ProfitLoss	-4520064
CY2021	us-gaap	Profit Loss ProfitLoss	272881
CY2022	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	14383
CY2021	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	2930894
CY2021	cbdy	Net Gain Loss On Settlement Of Liability NetGainLossOnSettlementOfLiability	26049
CY2022	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	1660
CY2021	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	4969
CY2022	cbdy	Recovery Of Sales Tax Recoverable RecoveryOfSalesTaxRecoverable	496
CY2021	cbdy	Recovery Of Sales Tax Recoverable RecoveryOfSalesTaxRecoverable	19453
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	885229
CY2021	us-gaap	Depreciation And Amortization DepreciationAndAmortization	971524
CY2022	us-gaap	Operating Lease Expense OperatingLeaseExpense	258916
CY2021	us-gaap	Operating Lease Expense OperatingLeaseExpense	266757
CY2022	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	354736
CY2021	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-272995
CY2022	cbdy	Debt Issuance Costs DebtIssuanceCosts	51599
CY2021	cbdy	Debt Issuance Costs DebtIssuanceCosts	52797
CY2022	cbdy	Impairment Of Inventory ImpairmentOfInventory	99000
CY2022	cbdy	Impairment Of Goodwill ImpairmentOfGoodwill	3315749
CY2021	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-2400
CY2022	cbdy	Increase Decrease In Sales Tax Recoverable IncreaseDecreaseInSalesTaxRecoverable	58310
CY2021	cbdy	Increase Decrease In Sales Tax Recoverable IncreaseDecreaseInSalesTaxRecoverable	73471
CY2021	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	-74751
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-466139
CY2021	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	1417751
CY2022	cbdy	Change In Operating Lease Liability Net ChangeInOperatingLeaseLiabilityNet	329473
CY2021	cbdy	Change In Operating Lease Liability Net ChangeInOperatingLeaseLiabilityNet	333782
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1014828
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	100118
CY2022	cbdy	Payments For Proceeds From Property Plant And Equipment PaymentsForProceedsFromPropertyPlantAndEquipment	314
CY2021	cbdy	Payments For Proceeds From Property Plant And Equipment PaymentsForProceedsFromPropertyPlantAndEquipment	-11876
CY2022	us-gaap	Payments For Proceeds From Businesses And Interest In Affiliates PaymentsForProceedsFromBusinessesAndInterestInAffiliates	-1015354
CY2021	us-gaap	Payments For Proceeds From Businesses And Interest In Affiliates PaymentsForProceedsFromBusinessesAndInterestInAffiliates	1417842
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	1015040
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1405966
CY2021	us-gaap	Proceeds From Repayments Of Bank Overdrafts ProceedsFromRepaymentsOfBankOverdrafts	-1058
CY2022	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	269150
CY2021	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	314740
CY2022	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	136476
CY2021	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	1027807
CY2022	cbdy	Payment For Settlement Payable PaymentForSettlementPayable	10000
CY2021	cbdy	Payment For Settlement Payable PaymentForSettlementPayable	90000
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	122674
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1251489
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	122886
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-54359
CY2022	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-12704
CY2021	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-5119
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	122151
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	181629
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	232333
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	122151
CY2021	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	2648
CY2022	us-gaap	Noncash Or Part Noncash Acquisition Intangible Assets Acquired1 NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1	280
CY2021	us-gaap	Noncash Or Part Noncash Acquisition Intangible Assets Acquired1 NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1	1294
CY2022	us-gaap	Interest Paid Net InterestPaidNet	2132332
CY2021	us-gaap	Interest Paid Net InterestPaidNet	480578
CY2022Q4	us-gaap	Area Of Land AreaOfLand	44000
CY2020	cbdy	Class Of Warrant Or Right Warrants Exercised During Period ClassOfWarrantOrRightWarrantsExercisedDuringPeriod	0
CY2022	cbdy	Warrants Purchase WarrantsPurchase	7211213
CY2021	cbdy	Class Of Warrant Or Right Warrants Exercised During Period ClassOfWarrantOrRightWarrantsExercisedDuringPeriod	0
CY2022Q4	us-gaap	Settlement Liabilities Current SettlementLiabilitiesCurrent	0
CY2022Q2	cbdy	Fair Value Assumptions Term FairValueAssumptionsTerm	P2Y
CY2021Q4	cbdy	Settlement Liabilities Noncurrent SettlementLiabilitiesNoncurrent	10000
CY2022Q1	cbdy	Fair Value Assumptions Term FairValueAssumptionsTerm	P2Y
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2022Q4	cbdy	Working Capital Deficit WorkingCapitalDeficit	6358008
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-30783678
CY2022	us-gaap	Use Of Estimates UseOfEstimates	<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">USE OF ESTIMATES</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements, and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from those estimates.</p>
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2022Q4	cbdy	Business Acquisition Fair Value Of Equity Interest Issued Or Issuable BusinessAcquisitionFairValueOfEquityInterestIssuedOrIssuable	176
CY2022Q3	cbdy	Business Acquisition Fair Value Of Equity Interest Issued Or Issuable BusinessAcquisitionFairValueOfEquityInterestIssuedOrIssuable	288
CY2022	cbdy	Revenue From Investments In Joint Venture RevenueFromInvestmentsInJointVenture	3916539
CY2021	cbdy	Revenue From Investments In Joint Venture RevenueFromInvestmentsInJointVenture	2198592
CY2022	cbdy	Foreign Currency Translation ForeignCurrencyTranslation	<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">FOREIGN CURRENCY TRANSLATION</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">The functional currency of the Company’s Canadian-based subsidiary is the Canadian dollar, and the US-based parent is the U.S. dollar. In addition, effective April 1, 2019, the Company changed its functional currency from United States Dollar to Canadian Dollar thereby having an impact on additional paid-in capital and accumulated comprehensive income (loss). The presentation currency of the Company </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">has remained unchanged at United States Dollar. Transactions denominated in currencies other than the functional currency are translated into the functional currency at the exchange rates prevailing at the dates of the transaction. Monetary assets and liabilities denominated in foreign currencies are translated using the exchange rate prevailing at the balance sheet date. Non-monetary assets and liabilities are translated using the historical rate on the date of the transaction. All exchange gains or losses arising from the translation of these foreign currency transactions are included in net income (loss) for the year. In translating the consolidated financial statements of the Company and its Canadian subsidiaries from their functional currency into the Company’s reporting currency of United States dollars, balance sheet accounts are translated using the closing exchange rate in effect at the balance sheet date and income and expense accounts are translated using an average exchange rate prevailing during the reporting period. Adjustments resulting from the translation, if any, are included in cumulative other comprehensive income (loss) in stockholders’ equity. The Company has not, to the date of these consolidated financial statements, entered into derivative instruments to offset the impact of foreign currency fluctuations.</p>
CY2022	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">CONCENTRATION OF RISK</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash. The Company places its cash with high-quality banking institutions. The Company did not have cash balances in excess of the Federal Deposit Insurance Corporation limit as of December 31, 2022 and 2021.</p>
CY2022Q2	cbdy	Business Acquisition Fair Value Of Equity Interest Issued Or Issuable BusinessAcquisitionFairValueOfEquityInterestIssuedOrIssuable	306
CY2022Q1	cbdy	Business Acquisition Fair Value Of Equity Interest Issued Or Issuable BusinessAcquisitionFairValueOfEquityInterestIssuedOrIssuable	430
CY2021Q4	cbdy	Share Based Compensation Share Based Payments Forfeiture Rate ShareBasedCompensationShareBasedPaymentsForfeitureRate	0
CY2021Q3	cbdy	Share Based Compensation Share Based Payments Forfeiture Rate ShareBasedCompensationShareBasedPaymentsForfeitureRate	0
CY2021Q2	cbdy	Share Based Compensation Share Based Payments Forfeiture Rate ShareBasedCompensationShareBasedPaymentsForfeitureRate	0
CY2022Q4	us-gaap	Inventory Net InventoryNet	0
CY2021Q4	us-gaap	Inventory Net InventoryNet	99000
CY2022	us-gaap	Inventory Write Down InventoryWriteDown	99000
CY2022	cbdy	Impairment Of Inventory ImpairmentOfInventory	99000
CY2021Q1	cbdy	Share Based Compensation Share Based Payments Forfeiture Rate ShareBasedCompensationShareBasedPaymentsForfeitureRate	0
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice	0.250
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice	0.250
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	41714
CY2021Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	44567
CY2022Q4	cbdy	Allowance On Value Added Tax Recoverable AllowanceOnValueAddedTaxRecoverable	0
CY2021Q4	cbdy	Allowance On Value Added Tax Recoverable AllowanceOnValueAddedTaxRecoverable	509
CY2017Q3	us-gaap	Area Of Land AreaOfLand	44000
CY2019Q2	us-gaap	Area Of Land AreaOfLand	44000
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	8227904
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2673679
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5554225
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	3
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	3.02
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	3.04
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	3.06
CY2021Q4	cbdy	Fair Value Assumptions Term FairValueAssumptionsTerm	P2Y
CY2022	cbdy	Number Of Customers To Whom Revenue Was Sold NumberOfCustomersToWhomRevenueWasSold	13
CY2021	cbdy	Number Of Customers To Whom Revenue Was Sold NumberOfCustomersToWhomRevenueWasSold	10
CY2022Q4	cbdy	Assets Balance Of Joint Venture AssetsBalanceOfJointVenture	10913576
CY2022Q4	cbdy	Assets Balance Of Joint Venture AssetsBalanceOfJointVenture	8057493
CY2021Q4	cbdy	Assets Balance Of Joint Venture AssetsBalanceOfJointVenture	4830446
CY2021Q4	cbdy	Assets Balance Of Joint Venture AssetsBalanceOfJointVenture	3810256
CY2022Q4	cbdy	Liabilities Balance Of Joint Venture LiabilitiesBalanceOfJointVenture	11181077
CY2022Q4	cbdy	Liabilities Balance Of Joint Venture LiabilitiesBalanceOfJointVenture	8254989
CY2021Q4	cbdy	Liabilities Balance Of Joint Venture LiabilitiesBalanceOfJointVenture	6020535
CY2021Q4	cbdy	Liabilities Balance Of Joint Venture LiabilitiesBalanceOfJointVenture	4748998
CY2022Q4	cbdy	Equity Of Joint Venture EquityOfJointVenture	-267501
CY2022Q4	cbdy	Equity Of Joint Venture EquityOfJointVenture	-197496
CY2021Q4	cbdy	Equity Of Joint Venture EquityOfJointVenture	-1190089
CY2021Q4	cbdy	Equity Of Joint Venture EquityOfJointVenture	-938742
CY2021	cbdy	Class Of Warrant Or Right Warrants Exercised During Period ClassOfWarrantOrRightWarrantsExercisedDuringPeriod	0
CY2021Q3	cbdy	Fair Value Assumptions Term FairValueAssumptionsTerm	P2Y
CY2021Q2	cbdy	Fair Value Assumptions Term FairValueAssumptionsTerm	P2Y
CY2021Q1	cbdy	Fair Value Assumptions Term FairValueAssumptionsTerm	P2Y
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	2296935
CY2022Q4	cbdy	Accrued Consulting And Construction Services AccruedConsultingAndConstructionServices	154811
CY2022Q4	us-gaap	Interest Payable Current InterestPayableCurrent	739130
CY2022Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	906596
CY2021Q4	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	2885909
CY2021Q4	cbdy	Accrued Customer Advance For Sales AccruedCustomerAdvanceForSales	394400
CY2021Q4	cbdy	Accrued Consulting And Construction Services AccruedConsultingAndConstructionServices	163101
CY2021Q4	us-gaap	Interest Payable Current InterestPayableCurrent	952376
CY2021Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	973017
CY2022Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	1736964
CY2022Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	3076207
CY2022Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	2881781
CY2022Q4	us-gaap	Long Term Debt LongTermDebt	7694952
CY2022Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	1736964
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	5957988
CY2020Q3	cbdy	Debt Issuance Costs DebtIssuanceCosts	251518
CY2022Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	129764
CY2022Q4	us-gaap	Deferred Finance Costs Current Net DeferredFinanceCostsCurrentNet	49539
CY2022Q4	us-gaap	Deferred Finance Costs Noncurrent Net DeferredFinanceCostsNoncurrentNet	80225
CY2022Q4	cbdy	Accrued Interest Converted Into Principal AccruedInterestConvertedIntoPrincipal	258405
CY2022Q4	cbdy	Accrued Interest Converted Into Principal AccruedInterestConvertedIntoPrincipal	350000
CY2022	us-gaap	Interest Expense Debt InterestExpenseDebt	37
CY2021	us-gaap	Interest Expense Debt InterestExpenseDebt	109
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2022	us-gaap	Line Of Credit Facility Periodic Payment Interest LineOfCreditFacilityPeriodicPaymentInterest	645340
CY2022	us-gaap	Line Of Credit Facility Periodic Payment Interest LineOfCreditFacilityPeriodicPaymentInterest	874089
CY2022Q4	cbdy	Line Of Credit Facility Accrued Interest LineOfCreditFacilityAccruedInterest	436226
CY2022Q4	cbdy	Line Of Credit Facility Accrued Interest LineOfCreditFacilityAccruedInterest	590852
CY2022	cbdy	Number Of Operating Lease Facilities NumberOfOperatingLeaseFacilities	2
CY2022Q4	us-gaap	Lessee Operating Lease Discount Rate LesseeOperatingLeaseDiscountRate	0.16
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	326696
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	322677
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	325904
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	329163
CY2022Q4	cbdy	Lessee Operating Lease Liability Payments Due After Year Four LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour	1121545
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	2425985
CY2022Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	995780
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	1430205
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	110586
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1319619
CY2022	cbdy	Gross Operating Lease Expense GrossOperatingLeaseExpense	258916
CY2021	cbdy	Gross Operating Lease Expense GrossOperatingLeaseExpense	266757
CY2022	cbdy	Gross Operating Leases Rent And Utilities Expenses GrossOperatingLeasesRentAndUtilitiesExpenses	594498
CY2021	cbdy	Gross Operating Leases Rent And Utilities Expenses GrossOperatingLeasesRentAndUtilitiesExpenses	417157
CY2022	cbdy	Recoverable Expenses From Jv Co Related To Rent And Utilities RecoverableExpensesFromJvCoRelatedToRentAndUtilities	927473
CY2021	cbdy	Recoverable Expenses From Jv Co Related To Rent And Utilities RecoverableExpensesFromJvCoRelatedToRentAndUtilities	682153
CY2022	cbdy	Operating Lease Expenses Total OperatingLeaseExpensesTotal	-74059
CY2021	cbdy	Operating Lease Expenses Total OperatingLeaseExpensesTotal	1761
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice	0.300
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice	0.300
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice	0.250
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice	0.250
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	2.79
CY2021Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	7902
CY2022	cbdy	Effect Of Conversion Of Convertible Notes EffectOfConversionOfConvertibleNotes	0
CY2022	cbdy	Derivative Liability Changes Due To Issuance DerivativeLiabilityChangesDueToIssuance	0
CY2022	cbdy	Change In Fair Value Of Derivative Liability ChangeInFairValueOfDerivativeLiability	7223
CY2022Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	15125
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	1000000
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	1000000
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	850000000
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	850000000
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	617025999
CY2022	us-gaap	Conversion Of Stock Shares Converted1 ConversionOfStockSharesConverted1	100
CY2022	cbdy	Schedule Of Shares To Be Issued ScheduleOfSharesToBeIssued	<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;"></span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:27.75%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;"></span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;"></span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;"></span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;"></span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;"></span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;"></span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.01%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;"></span></p></div></div></td><td style="vertical-align:bottom;width:52.29%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;"></span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:27.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Services</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 115,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 73,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;width:52.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">80,000 shares of common stock to be issued as compensation to advisers and consultants. These were recorded at fair value of $52,000, based on the market price of the Company’s stock on the date of issue. 35,000 to be issued as settlement of the amount due for website development services amounting to $247,306. The fair value of the shares on the date of settlement was $21,000, resulting in a gain on settlement amounting to $226,306 during the year ended December 31, 2017.</p></td></tr><tr><td style="vertical-align:bottom;width:27.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Private placements</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 346,296</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 18,787</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;width:52.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Consideration for private placements with the fair value based on cash proceeds received. Proper allocation between common stock and additional paid-in capital of the amount received will be completed in the period when the shares are issued.</p></td></tr><tr><td style="vertical-align:bottom;width:27.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Settlement of loans of CannaKorp</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 930,240</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 80,838</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;width:52.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Refer to Note 14 for details.</p></td></tr><tr><td style="vertical-align:bottom;width:27.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Agreement with Serious Seeds</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.42%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 187,488</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,557</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;width:52.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">As consideration for intellectual property rights granted by Smit. The fair value is based on the market price of the Company’s stock on the date of issue as per the agreement.</p></td></tr><tr><td style="vertical-align:bottom;width:27.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.42%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,579,024</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.03%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 175,182</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:52.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;"></span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;"></span></p>
CY2022	us-gaap	Stock Issued During Period Shares Issued For Services StockIssuedDuringPeriodSharesIssuedForServices	115000
CY2022	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	73000
CY2022Q4	cbdy	Share Based Compensation Share Based Payments Forfeiture Rate ShareBasedCompensationShareBasedPaymentsForfeitureRate	0
CY2022Q3	cbdy	Share Based Compensation Share Based Payments Forfeiture Rate ShareBasedCompensationShareBasedPaymentsForfeitureRate	0
CY2022Q2	cbdy	Share Based Compensation Share Based Payments Forfeiture Rate ShareBasedCompensationShareBasedPaymentsForfeitureRate	0
CY2022Q1	cbdy	Share Based Compensation Share Based Payments Forfeiture Rate ShareBasedCompensationShareBasedPaymentsForfeitureRate	0
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice	0.300
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice	0.300
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice	0.300
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice	0.300
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	2.79
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	2.99
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	3.06
CY2022Q4	cbdy	Fair Value Assumptions Term FairValueAssumptionsTerm	P2Y
CY2022Q3	cbdy	Fair Value Assumptions Term FairValueAssumptionsTerm	P2Y
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2021Q4	cbdy	Business Acquisition Fair Value Of Equity Interest Issued Or Issuable BusinessAcquisitionFairValueOfEquityInterestIssuedOrIssuable	524
CY2021	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-567466
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0
CY2021Q3	cbdy	Business Acquisition Fair Value Of Equity Interest Issued Or Issuable BusinessAcquisitionFairValueOfEquityInterestIssuedOrIssuable	807
CY2021Q2	cbdy	Business Acquisition Fair Value Of Equity Interest Issued Or Issuable BusinessAcquisitionFairValueOfEquityInterestIssuedOrIssuable	114211
CY2021Q1	cbdy	Business Acquisition Fair Value Of Equity Interest Issued Or Issuable BusinessAcquisitionFairValueOfEquityInterestIssuedOrIssuable	2152191
CY2022Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	53950001
CY2021Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	350178339
CY2020Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	2948823
CY2021	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Issues FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues	3674
CY2021	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Period Increase Decrease FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease	-2930402
CY2021Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	22095
CY2022	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Issues FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues	1221
CY2022	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Period Increase Decrease FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease	-22827
CY2022Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	489
CY2022	us-gaap	Loss Contingency Damages Sought Value LossContingencyDamagesSoughtValue	1375309
CY2022	us-gaap	Loss Contingency Damages Sought Value LossContingencyDamagesSoughtValue	1862805
CY2022Q4	us-gaap	Loss Contingency Accrual At Carrying Value LossContingencyAccrualAtCarryingValue	10720
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2022	cbdy	Net Income Loss After Adjustment Of New Tax Law NetIncomeLossAfterAdjustmentOfNewTaxLaw	-949213
CY2021	cbdy	Net Income Loss After Adjustment Of New Tax Law NetIncomeLossAfterAdjustmentOfNewTaxLaw	57305
CY2022	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	3099
CY2021	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	624771
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-952312
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	5020076
CY2021Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	4067763
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	5020076
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	4067763
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0
CY2021Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	23905124
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	19370301
CY2022	cbdy	Operating Loss Expiration Period Description OperatingLossExpirationPeriodDescription	2042
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0
CY2022	dei	Auditor Name AuditorName	Fruci & Associates II, PLLC

Files In Submission

Name	View Source	Status
0001410578-23-000283-index-headers.html	Edgar Link	pending
0001410578-23-000283-index.html	Edgar Link	pending
0001410578-23-000283.txt	Edgar Link	pending
0001410578-23-000283-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
tmb-20221231.xsd	Edgar Link	pending
tmb-20221231x10k.htm	Edgar Link	pending
tmb-20221231x10k001.jpg	Edgar Link	pending
tmb-20221231x10k002.jpg	Edgar Link	pending
tmb-20221231xex31d1.htm	Edgar Link	pending
tmb-20221231xex32d1.htm	Edgar Link	pending
tmb-20221231_cal.xml	Edgar Link	unprocessable
tmb-20221231_def.xml	Edgar Link	unprocessable
tmb-20221231_lab.xml	Edgar Link	unprocessable
tmb-20221231_pre.xml	Edgar Link	unprocessable
tmb-20221231x10k_htm.xml	Edgar Link	completed

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CBDY
Target Group Inc. Stock $cbdy

2023 Q1 Form 10-K Financial Statement

#000141057823000283 Filed on March 17, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CBDY Target Group Inc. Stock $cbdy

2023 Q1 Form 10-K Financial Statement

#000141057823000283 Filed on March 17, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CBDY
Target Group Inc. Stock $cbdy